Appendix B: Panel Roster and Financial Disclosures
Syphilis
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Laura Bachmann | Centers for Disease Control and Prevention | None | N/A |
| Khalil Ghanem | The Johns Hopkins University School of Medicine | None | N/A |
| Matthew Hamill | The Johns Hopkins University School of Medicine | Chembio Diagnostics, Inc. | Honoraria |
Cepheid Chembio Diagnostics, Inc. Roche Diagnostics | Other | ||
| Edward W. Hook | University of Alabama at Birmingham Marnix E. Heersink School of Medicine | Visby Medical | Scientific Advisory Board |
| Arlene Sena | University of North Carolina at Chapel Hill School of Medicine | None | N/A |
| Irene Stafford | The University of Texas Health Science Center at Houston, McGovern Medical School | None | N/A |
| Susan Tuddenham* | The Johns Hopkins University School of Medicine | None | N/A |
| Kimberly Workowski | Emory University School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (17.93 KB)
- Full Guideline PDF (6.02 MB)
- Tables Only PDF (1.18 MB)